Champions Oncology Inc
CSBR
Market Cap$65.11M
Close$
$-5.05
168.5% downside
Current Fair Value
168.5% downsideOvervalued by 168.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $65.11 Million |
|---|---|
| Enterprise Value | $77.84 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.54 |
| Beta | 0.46 |
| Outstanding Shares | 13,593,766 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -19.17 |
|---|---|
| PEG | 6.9 |
| Price to Sales | 7.37 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.58 |
| Enterprise Value to EBIT | 11.53 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 2.91 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Champions Oncology Inc
143 employeesChampions Oncology is a data-driven research organization that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computa...